Literature DB >> 15592483

Substrate cycling between de novo lipogenesis and lipid oxidation: a thermogenic mechanism against skeletal muscle lipotoxicity and glucolipotoxicity.

A G Dulloo1, M Gubler, J P Montani, J Seydoux, G Solinas.   

Abstract

Life is a combustion, but how the major fuel substrates that sustain human life compete and interact with each other for combustion has been at the epicenter of research into the pathogenesis of insulin resistance ever since Randle proposed a 'glucose-fatty acid cycle' in 1963. Since then, several features of a mutual interaction that is characterized by both reciprocality and dependency between glucose and lipid metabolism have been unravelled, namely: the inhibitory effects of elevated concentrations of fatty acids on glucose oxidation (via inactivation of mitochondrial pyruvate dehydrogenase or via desensitization of insulin-mediated glucose transport),the inhibitory effects of elevated concentrations of glucose on fatty acid oxidation (via malonyl-CoA regulation of fatty acid entry into the mitochondria), and more recentlythe stimulatory effects of elevated concentrations of glucose on de novo lipogenesis, that is, synthesis of lipids from glucose (via SREBP1c regulation of glycolytic and lipogenic enzymes). This paper first revisits the physiological significance of these mutual interactions between glucose and lipids in skeletal muscle pertaining to both blood glucose and intramyocellular lipid homeostasis. It then concentrates upon emerging evidence, from calorimetric studies investigating the direct effect of leptin on thermogenesis in intact skeletal muscle, of yet another feature of the mutual interaction between glucose and lipid oxidation: that of substrate cycling between de novo lipogenesis and lipid oxidation. It is proposed that this energy-dissipating substrate cycling that links glucose and lipid metabolism to thermogenesis could function as a 'fine-tuning' mechanism that regulates intramyocellular lipid homeostasis, and hence contributes to the protection of skeletal muscle against lipotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592483     DOI: 10.1038/sj.ijo.0802861

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  19 in total

1.  Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation.

Authors:  Fengqi Hao; Miaomiao Tian; Xinbo Zhang; Xin Jin; Ying Jiang; Xue Sun; Yang Wang; Pinghui Peng; Jia Liu; Chaoyi Xia; Yunpeng Feng; Min Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

2.  Role of lactate in lipid metabolism, just always inhibiting lipolysis?

Authors:  Hai-Jun Xu
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

3.  Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

Authors:  J Agudo; M Martin; C Roca; M Molas; A S Bura; A Zimmer; F Bosch; R Maldonado
Journal:  Diabetologia       Date:  2010-09-11       Impact factor: 10.122

4.  De novo lipogenesis is suppressed during fasting but upregulated at population decline in cyclic voles.

Authors:  Petteri Nieminen; Kirsti Rouvinen-Watt; Lora Harris; Otso Huitu; Heikki Henttonen; Anne-Mari Mustonen
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-17

5.  Inactivation of UCP1 and the glycerol phosphate cycle synergistically increases energy expenditure to resist diet-induced obesity.

Authors:  Rea Anunciado-Koza; Jozef Ukropec; Robert A Koza; Leslie P Kozak
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

6.  Paradoxical coupling of triglyceride synthesis and fatty acid oxidation in skeletal muscle overexpressing DGAT1.

Authors:  Li Liu; Xiaojing Shi; Cheol Soo Choi; Gerald I Shulman; Katherine Klaus; K Sreekumaran Nair; Gary J Schwartz; Yiying Zhang; Ira J Goldberg; Yi-Hao Yu
Journal:  Diabetes       Date:  2009-08-12       Impact factor: 9.461

Review 7.  Lipidomics for studying metabolism.

Authors:  Xianlin Han
Journal:  Nat Rev Endocrinol       Date:  2016-07-29       Impact factor: 43.330

Review 8.  Mitochondrial protein phosphorylation: instigator or target of lipotoxicity?

Authors:  Wolfgang F Graier; Roland Malli; Gerhard M Kostner
Journal:  Trends Endocrinol Metab       Date:  2009-04-07       Impact factor: 12.015

9.  Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

Authors:  Chantale Simard; Paul Poirier
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

10.  Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics.

Authors:  Deborah L Diamond; Andrew J Syder; Jon M Jacobs; Christina M Sorensen; Kathie-Anne Walters; Sean C Proll; Jason E McDermott; Marina A Gritsenko; Qibin Zhang; Rui Zhao; Thomas O Metz; David G Camp; Katrina M Waters; Richard D Smith; Charles M Rice; Michael G Katze
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.